Vaqta NDC 0006-4831

Product information

Brand name (proprietary)

Vaqta

Generic name (nonproprietary)

hepatitis a vaccine, inactivated

Active ingredients

Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) — 25 [iU]/.5mL

Dosage form

Injection, Suspension

Route

Intramuscular

Labeler

Merck Sharp & Dohme LLC

Product type

Vaccine

Marketing category

BLA — Biologics License ApplicationApplication BLA 103606

Marketing start

Mar 29, 1996

Listing expires

Dec 31, 2026

Other FDA classes

Actively Acquired Immunity (Physiologic effect)Hepatitis A Vaccines (Chemical structure)Inactivated (Chemical structure)

Identifiers

Product ID 0006-4831_287d69ba-8eec-4e38-b787-ce9ddfb0e172SPL ID 287d69ba-8eec-4e38-b787-ce9ddfb0e172

Pharmacologic class

Inactivated Hepatitis A Virus Vaccine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N400006483141 followed by a unit qualifier and the quantity Copy

Package 00006-4831-41. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 103606

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.